Dr. Hans-Georg Eichler, will be retiring next month from his current position of Senior Medical Officer of the European Medicines Agency (EMA). After his retirement, he will be co-leading the … Read More
Dr Gigi Hirsch hosts fireside chat at the MIT Sloan Healthcare and Bioinnovations Conference
On February 26, Dr Hirsch hosted a conversation with Bill Sibold, Executive Vice President & Head of Sanofi Genzyme, Sanofi, entitled, “The Value of Downstream Innovation—Improving Patient Access to Groundbreaking … Read More
Tsega Meshesha, MS joins as FoCUS Program Manager
Tsega Meshesha, MS is a public health research specialist who designs evidence-based solutions to improve health outcomes. Having worked both domestically and internationally, she prides herself on being a trusted client … Read More
Scipher Medicine is the latest NEWDIGS collaborator for the LEAPS Project
Patient-centered collaboration for regimen optimization CAMBRIDGE, MA January 28, 2021 – Scipher Medicine, a precision immunology company matching patients with the most effective therapy, has joined the Massachusetts Institute of Technology Center for Biomedical Innovation’s … Read More
Dr Hirsch and Dr Larholt invited to NAS workshop
NEWDIGS Exutive Director Gigi Hirsch and Director of Research Kay Larholt were invited to participate in the National Academies of Science’s Envisioning a Transformed Clinical Trials Enterprise for 2030. This workshop is being … Read More
FoCUS Monthly Recap: January 2021
RESEARCH BRIEF Resource navigation challenges for patients and caregivers While the problem of finding system-wide, implementable precision financing models for curative and durable therapies involves all stakeholders, patients and caregivers … Read More
The NEWDIGS Initiative at MIT welcomes Cerevel Therapeutics as a new collaborator on the LEAPS Project
Collaboration to enhance the capacity of disease ecosystems for regimen optimization CAMBRIDGE, MA November 25, 2020 – Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat … Read More
LEAPS Monthly Recap: December 2020
NEW MEMBER NEWDIGS welcomes Cerevel Therapeutics as a new collaborator on the LEAPS Project Collaboration to enhance the capacity of disease ecosystems for regimen optimization Cerevel Therapeutics, a company dedicated … Read More
FoCUS Monthly Recap: December 2020
IN THE MEDIAMark Trusheim coauthored the article “Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions” published in Science Direct: Drug Discovery Today, November 24, 2020. This review … Read More
Downstream Innovation: Designing infrastructures and environments for real-world disease-focused learning
The LEAPS Project is advancing sustainable, patient-centered biomedical innovation through a new collaborative systems approach to the planning, production, and use of real-world evidence at the level of disease, not … Read More